UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome

European journal of case reports in internal medicine, 2020, Vol.7 (5), p.001675-001675

2020

Volltextzugriff (PDF)

The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

Rheumatology (Oxford, England), 2023-02, Vol.62 (SI), p.SI74-SI81

2023

Volltextzugriff (PDF)

Confirmation of −174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Pharmacogenetics and genomics, 2014-01, Vol.24 (1), p.1-5

2014

Volltextzugriff (PDF)

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies

Arthritis & rheumatology (Hoboken, N.J.), 2016-09, Vol.68 (9), p.2338-2344

2016

Volltextzugriff (PDF)

Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

Joint, bone, spine : revue du rhumatisme, 2014-03, Vol.81 (2), p.164-168

2014

Volltextzugriff (PDF)

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet’s disease

Human immunology, 2013-02, Vol.74 (2), p.230-233

2013

Volltextzugriff (PDF)

Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI

European radiology, 2021-11, Vol.31 (11), p.8208-8217

2021

Volltextzugriff (PDF)

Demyelinating disease in SLE: Is it multiple sclerosis or lupus?

Best practice & research. Clinical rheumatology, 2013-06, Vol.27 (3), p.405-424

2013

Volltextzugriff (PDF)

A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus

NeuroImage clinical, 2015-01, Vol.8 (C), p.337-344

2015

Volltextzugriff (PDF)

Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study

Rheumatic & musculoskeletal diseases open, 2021-11, Vol.7 (3), p.e001906

2021

Volltextzugriff (PDF)

Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more

British journal of clinical pharmacology, 2023-02

2023

Volltextzugriff (PDF)

Cluster analysis of an array of autoantibodies in neuropsychiatric systemic lupus erythematosus

Journal of rheumatology, 2014-08, Vol.41 (8), p.1720-1721

2014

Volltextzugriff (PDF)

Changes in White Matter Microstructure Suggest an Inflammatory Origin of Neuropsychiatric Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.1945-1954

2016

Volltextzugriff (PDF)

Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study

Rheumatology (Oxford, England), 2015-08, Vol.54 (8), p.1459-1463

2015

Volltextzugriff (PDF)

Three-month follow-up after severe COVID-19 infection: are chest CT results associated with respiratory outcomes and respiratory recovery in COVID-19 patients?

BMC pulmonary medicine, 2023-03, Vol.23 (1), p.74-74, Article 74

2023

Volltextzugriff (PDF)

Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152121-152121, Article 152121

2023

Volltextzugriff (PDF)

Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives

Drugs (New York, N.Y.), 2016-03, Vol.76 (4), p.459-483

2016

Volltextzugriff (PDF)

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.1143-1151

2020

Volltextzugriff (PDF)

Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go?

Frontiers in medicine, 2018-12, Vol.5, p.340-340

2018

Volltextzugriff (PDF)

Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints

NeuroImage clinical, 2021-01, Vol.30, p.102637-102637, Article 102637

2021

Volltextzugriff (PDF)

Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis

Journal of the American Academy of Dermatology, 2013-12, Vol.69 (6), p.938-946

2013

Volltextzugriff (PDF)

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review

Rheumatology advances in practice, 2022-12, Vol.6 (3)

2022

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome

The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

Confirmation of −174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet’s disease

Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI

Demyelinating disease in SLE: Is it multiple sclerosis or lupus?

A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus

Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study

Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more

Cluster analysis of an array of autoantibodies in neuropsychiatric systemic lupus erythematosus

Changes in White Matter Microstructure Suggest an Inflammatory Origin of Neuropsychiatric Systemic Lupus Erythematosus

Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study

Three-month follow-up after severe COVID-19 infection: are chest CT results associated with respiratory outcomes and respiratory recovery in COVID-19 patients?

Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go?

Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints

PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6

Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review

Suchergebnisse filtern